"Medroxyprogesterone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
(6 alpha)-17-Hydroxy-6-methylpregn-4-ene-3,20-dione. A synthetic progestational hormone used in veterinary practice as an estrus regulator.
| Descriptor ID |
D008525
|
| MeSH Number(s) |
D04.210.500.745.745.654.829.395.700
|
| Concept/Terms |
Medroxyprogesterone- Medroxyprogesterone
- Methylhydroxyprogesterone
- 17 alpha-Hydroxy-6 alpha-Methylprogesterone
- 17 alpha Hydroxy 6 alpha Methylprogesterone
|
Below are MeSH descriptors whose meaning is more general than "Medroxyprogesterone".
Below are MeSH descriptors whose meaning is more specific than "Medroxyprogesterone".
This graph shows the total number of publications written about "Medroxyprogesterone" by people in this website by year, and whether "Medroxyprogesterone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Medroxyprogesterone" by people in Profiles.
-
Membrane-initiated steroid signaling (MISS): genomic steroid action starts at the plasma membrane. J Steroid Biochem Mol Biol. 2003 May; 85(1):9-23.
-
Patients' understanding of their own disease and survival potential in patients with metastatic breast cancer. Breast Cancer Res Treat. 2000 May; 61(2):145-50.
-
Bone mineral changes in young women with hypothalamic amenorrhea treated with oral contraceptives, medroxyprogesterone, or placebo over 12 months. Am J Obstet Gynecol. 1997 May; 176(5):1017-25.
-
Clinical trial of high-dose oral medroxyprogesterone acetate in the treatment of metastatic breast cancer and review of the literature. Cancer. 1988 Jun 01; 61(11):2161-7.
-
The treatment of retroperitoneal fibromatosis with medroxyprogesterone acetate. Obstet Gynecol. 1987 Sep; 70(3 Pt 2):502-4.
-
Endocrine therapy testing of human breast cancers in the soft agar clonogenic assay. Breast Cancer Res Treat. 1985; 6(3):229-35.
-
Oncodevelopmental and hormonal regulation of alpha 1-fetoprotein gene expression. Adv Enzyme Regul. 1983; 21:73-99.
-
Potential and problems with growth of breast cancer in a human tumor cloning system. Breast Cancer Res Treat. 1981; 1(2):141-8.